Entheon Biomedical Corp. (CSE:ENBI)
Canada
· Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Dec 5, 2025, 9:30 AM EST
Entheon Biomedical Balance Sheet
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2019 |
| Cash & Equivalents | 0.38 | 0.14 | 0.34 | 0.68 | 2.05 | 2.79 | Upgrade
|
| Trading Asset Securities | - | - | - | - | - | 0.05 | Upgrade
|
| Cash & Short-Term Investments | 0.38 | 0.14 | 0.34 | 0.68 | 2.05 | 2.84 | Upgrade
|
| Cash Growth | 67.20% | -60.39% | -49.33% | -66.81% | -27.77% | 2418.31% | Upgrade
|
| Other Receivables | 0.01 | 0 | 0.01 | 0.04 | 0.03 | 0.08 | Upgrade
|
| Receivables | 0.01 | 0 | 0.01 | 0.04 | 0.03 | 0.08 | Upgrade
|
| Inventory | - | - | - | - | 0.03 | - | Upgrade
|
| Prepaid Expenses | 0.01 | 0.04 | 0.05 | 0.02 | 1.1 | 1.49 | Upgrade
|
| Total Current Assets | 0.4 | 0.18 | 0.4 | 0.74 | 3.21 | 4.4 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.16 | 0.01 | Upgrade
|
| Long-Term Investments | - | - | - | - | 0.7 | 0.06 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 5.9 | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.03 | - | - | Upgrade
|
| Total Assets | 0.41 | 0.19 | 0.4 | 0.77 | 9.98 | 4.47 | Upgrade
|
| Accounts Payable | 0.02 | 0.04 | 0.08 | 0.14 | 0.93 | 0.72 | Upgrade
|
| Accrued Expenses | 0 | 0 | 0 | 0.02 | - | 0 | Upgrade
|
| Total Current Liabilities | 0.02 | 0.04 | 0.09 | 0.15 | 0.93 | 0.73 | Upgrade
|
| Total Liabilities | 0.02 | 0.04 | 0.09 | 0.15 | 0.93 | 0.73 | Upgrade
|
| Common Stock | 20.61 | 20.11 | 19.96 | 19.35 | 19.35 | 7.15 | Upgrade
|
| Retained Earnings | -20.95 | -20.92 | -21.31 | -21.61 | -13.55 | -4.66 | Upgrade
|
| Comprehensive Income & Other | 0.73 | 0.96 | 1.66 | 2.87 | 3.24 | 1.26 | Upgrade
|
| Shareholders' Equity | 0.39 | 0.15 | 0.32 | 0.61 | 9.05 | 3.74 | Upgrade
|
| Total Liabilities & Equity | 0.41 | 0.19 | 0.4 | 0.77 | 9.98 | 4.47 | Upgrade
|
| Net Cash (Debt) | 0.38 | 0.14 | 0.34 | 0.68 | 2.05 | 2.84 | Upgrade
|
| Net Cash Growth | 67.20% | -60.39% | -49.33% | -66.81% | -27.77% | 2487.89% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.02 | 0.06 | 0.12 | 0.38 | 1.03 | Upgrade
|
| Filing Date Shares Outstanding | 13.86 | 8.86 | 5.91 | 5.91 | 5.91 | 4.04 | Upgrade
|
| Total Common Shares Outstanding | 13.86 | 8.86 | 5.91 | 5.91 | 5.91 | 4.04 | Upgrade
|
| Working Capital | 0.38 | 0.14 | 0.31 | 0.59 | 2.28 | 3.68 | Upgrade
|
| Book Value Per Share | 0.03 | 0.02 | 0.05 | 0.10 | 1.53 | 0.93 | Upgrade
|
| Tangible Book Value | 0.39 | 0.15 | 0.32 | 0.61 | 3.15 | 3.74 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.02 | 0.05 | 0.10 | 0.53 | 0.93 | Upgrade
|
| Machinery | - | - | - | - | 0.16 | 0.01 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.04 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.